New data support tailoring regional nodal irradiation in patients treated with neoadjuvant chemotherapy on the basis of their ...

A UK biotech firm spent years gathering genetic data that has uncovered 1 million previously unknown microbial species and ...

The biotech industry faces a mix of longstanding and novel political challenges amid President Donald Trump’s second term.

Among patients with COPD and type 2 inflammation, investigator-reported emphysema did not change benefits seen with dupilumab ...

The VERONA trial evaluated the safety and efficacy of venetoclax with azacitidine in treatment-naïve adults with higher-risk MDS.

In this video, Susana M. Campos, MD, MPH, discusses results from a phase 3 clinical trial of dostarlimab and niraparib in advanced ovarian cancer, presented at ASCO Annual Meeting.The FIRST/ENGOT-OV44 ...

The severe asthma treatment market is experiencing robust expansion, driven by rising disease prevalence, improved diagnostic approaches, and breakthrough therapeutic developments from key ...

The AI unicorn's Perturb-seq atlas is publicly available and detects dose-dependent genetic effects to enhance predictive power for drug discovery.

Precision oncology leader joins world-class team as company enters next phase of translating AI-driven drug discovery into ...

FDA Commissioner Dr Martin Makary took the stage at BIO 2025 to detail the way he and his team have been challenging “deeply ...